Physician profile
Neil Bhamb
NPI 1629235791
$6,928.04
in general payments reported to CMS, 2019-2025
12 companies · $481 in 2025
The $481 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,163 · 2020: $170 · 2022: $475 · 2023: $16.76 · 2024: $623 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,239.66 | 2019-2020 | |
| Nuvasive, INC. | $1,516.94 | 2019 | |
| Great Lakes Orthopedics | $1,460.62 | 2019 | |
| Globus Medical, INC. | $1,024.23 | 2024-2025 | Xlif, Reline, Modulus |
| Medtronic, INC. | $281.58 | 2022 | |
| Alphatec Spine, INC | $193.41 | 2022 | |
| Orthofix Medical, INC. | $57.80 | 2024-2025 | Spinal-Stim |
| Zimmer Biomet Holdings, INC. | $57.44 | 2019 | |
| Stryker Corporation | $51.98 | 2019-2025 | Core, Nico Brainpath |
| Endo Pharmaceuticals INC. | $18.02 | 2019 | |
| Amgen INC. | $16.76 | 2023 | Prolia, Evenity |
| Electronic Waveform Lab, INC. | $9.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Bhamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.